BrainStorm Cell Therapeutics Inc. To Present At World Stem Cells and Regenerative Medicine Congress

NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI), a leading developer of adult stem cell technologies and therapeutics is pleased to announce that Dr. Avinoam Kadouri, BrainStorm’s Chief Technology Advisor, has been invited to act as a Chairman at the World Stem Cells and Regenerative Medicine Congress being held May 11 – 13, in London, UK.

MORE ON THIS TOPIC